Role of diet on non-alcoholic fatty liver disease: An updated narrative review

被引:8
|
作者
Dimitrios Papandreou [1 ]
Eleni Andreou [2 ]
机构
[1] Department of Natural Science and Public Health, CSSH, Zayed University
[2] Department of Life and Health Science, University of Nicosia
关键词
Diet; Non-alcoholic fatty acids; Fatty acids; Obesity; Insulin resistance;
D O I
暂无
中图分类号
R575.5 [肝代谢障碍];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this article review is to update what is known about the role of diet on non-alcoholic fatty liver disease(NAFLD). NAFLD is the most common cause of chronic liver disease in the developed world and is considered to be a spectrum, ranging from fatty infiltration of the liver alone(steatosis), which may lead to fatty infiltration with inflammation known as non alcoholic steatohepatitis While the majority of individualswith risk factors like obesity and insulin resistance have steatosis, only few people may develop steatohepatitis. Current treatment relies on weight loss and exercise, although various insulin-sensitizing medications appear promising. Weight loss alone by dietary changes has been shown to lead to histological improvement in fatty liver making nutrition therapy to become a cornerstone of treatment for NAFLD. Supplementation of vitamin E, C and omega 3 fatty acids are under consideration with some conflicting data. Moreover, research has been showed that saturated fat, trans-fatty acid, carbohydrate, and simple sugars(fructose and sucrose) may play significant role in the intrahepatic fat accumulation. However, true associations with specific nutrients yet to be clarified.
引用
收藏
页码:575 / 582
页数:8
相关论文
共 50 条
  • [31] Role of nutrition in non-alcoholic fatty liver disease
    Peter, Szabolcs
    Weber, Peter
    ANNALS OF NUTRITION AND METABOLISM, 2015, 67 : 91 - 91
  • [32] The Role of Fucoxanthin in Non-Alcoholic Fatty Liver Disease
    Winarto, Jessica
    Song, Dae-Geun
    Pan, Cheol-Ho
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [33] The role of elastography in non-alcoholic fatty liver disease
    Liguori, Antonio
    Ainora, Maria E.
    Riccardi, Laura
    De Matthaeis, Nicoletta
    Pizzolante, Fabrizio
    Gasbarrini, Antonio
    Zocco, Maria A.
    Grieco, Antonio
    Rapaccini, Gianludovico
    Miele, Luca
    MINERVA GASTROENTEROLOGY, 2021, 67 (02): : 164 - 170
  • [34] Role of Leptin in Non-Alcoholic Fatty Liver Disease
    Jimenez-Cortegana, Carlos
    Garcia-Galey, Alba
    Tami, Malika
    del Pino, Pilar
    Carmona, Isabel
    Lopez, Soledad
    Alba, Gonzalo
    Sanchez-Margalet, Victor
    BIOMEDICINES, 2021, 9 (07)
  • [35] Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
    Changez, Mah I. Kan
    Mubeen, Maryam
    Zehra, Monezahe
    Samnani, Inara
    Rasool, Aniqa Abdul
    Mohan, Anmol
    Ul Wara, Um
    Tejwaney, Usha
    Kumar, Vikash
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [37] A Comprehensive Review on Non-Alcoholic Fatty Liver Disease
    Sahu, Prerna
    Chhabra, Pratyaksh
    Mehendale, Ashok M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [38] Non-alcoholic fatty liver disease:An expanded review
    Mark Benedict
    Xuchen Zhang
    World Journal of Hepatology, 2017, (16) : 715 - 732
  • [39] A concise review of non-alcoholic fatty liver disease
    Than, Nwe Ni
    Newsome, Philip N.
    ATHEROSCLEROSIS, 2015, 239 (01) : 192 - 202
  • [40] THE ROLE OF BLOOD GROUPS IN NON-ALCOHOLIC FATTY LIVER DISEASE AND NON-ALCOHOLIC STEATOHEPATITIS
    Karagoz, Hatice
    Erden, Abdulsamet
    Ozer, Ozerhan
    Cetinkaya, Ali
    Avci, Deniz
    Gencer, Vedat
    Arik, Ferhat
    Kalan, Ugur
    Gorkem, Hasan
    Karaman, Hatice
    Karaman, Ahmet
    ACTA MEDICA MEDITERRANEA, 2017, 33 (02): : 205 - 210